C.J. Bol
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 2
- Colorectal Cancer Treatments and Studies 2
-
- Cardiac Valve Diseases and Treatments 2
-
- Pharmacological Effects and Toxicity Studies 2
-
- Coronary Interventions and Diagnostics 2
- Co-authors
- Peter PalmerR. WoestenborghsAte van der GaastLia van ZuylenAlex SparreboomJaap VerweijC. ChowR. B. Nussenblatt
- Cited by
- OncologyHematologyGenetics
- Journals
- Journal of Clinical Oncology (2 papers)European Journal of Cancer (2 papers)Journal of Interventional Cardiology (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
C.J. Bol
9 papers receiving 539 citations
Peers
Comparison fields: 5 of 57
- Oncology 391
- Hematology 61
- Genetics 46
- Pharmacology 35
- Molecular Biology 271
Countries citing papers authored by C.J. Bol
This map shows the geographic impact of C.J. Bol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Bol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Bol more than expected).
Fields of papers citing papers by C.J. Bol
This network shows the impact of papers produced by C.J. Bol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Bol. The network helps show where C.J. Bol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C.J. Bol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 10 | |
| 2 | 2008 | 16 | |
| 3 | 2002 | 8 | |
| 4 | 2002 | 55 | |
| 5 | 2002 | 110 | |
| 6 | 2001 | 55 | |
| 7 | The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel. | 2000 | 84 |
| 8 | 2000 | 218 | |
| 9 | 1999 | 1 | |
| 10 | 1987 | 0 |
About C.J. Bol
C.J. Bol is a scholar working on Pharmacology, Oncology, Pediatrics, Perinatology and Child Health, Cardiology and Cardiovascular Medicine and Neurology, having authored 10 papers that have together received 557 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Cardiac Valve Diseases and Treatments (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Coronary Interventions and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (391 citations), Hematology (61 citations), Genetics (46 citations), Pharmacology (35 citations) and Molecular Biology (271 citations). C.J. Bol has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Peter Palmer, R. Woestenborghs, Ate van der Gaast, Lia van Zuylen, Alex Sparreboom, Jaap Verweij, C. Chow, R. B. Nussenblatt, Charles L. Bowden and Vladimir Piotrovsky. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Journal of Interventional Cardiology, American Heart Journal and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.